Darden Wealth Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.07M Buy
1,159
+34
+3% +$34.5K 0.54% 40
2025
Q4
$1.21M Buy
1,125
+100
+10% +$95.6K 0.59% 43
2025
Q3
$782K Sell
1,025
-300
-23% -$223K 0.41% 56
2025
Q2
$1.03M Sell
1,325
-120
-8% -$93.2K 0.62% 43
2025
Q1
$1.19M Sell
1,445
-10
-0.7% -$8.32K 0.93% 30
2024
Q4
$1.12M Sell
1,455
-60
-4% -$49.7K 0.76% 32
2024
Q3
$1.34M Buy
1,515
+55
+4% +$49.4K 0.96% 23
2024
Q2
$1.32M Hold
1,460
0.8% 25
2024
Q1
$1.14M Buy
1,460
+100
+7% +$71.2K 0.89% 29
2023
Q4
$793K Buy
+1,360
New +$794K 0.76% 37

Other funds holding LLY

Darden Wealth Group's LLY Position: Q1 2026 in Review

Darden Wealth Group increased its Eli Lilly (LLY) stake by 3% in Q1 2026, buying an estimated $34.5K and bringing the position to 1,159 shares worth $1.07M. The position accounts for 0.54% of the portfolio, ranked #40.

Darden Wealth Group first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.34M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Darden Wealth Group held 1,159 shares of Eli Lilly worth $1.07M as of Q1 2026.
  • Darden Wealth Group bought 34 Eli Lilly shares in Q1 2026, an estimated $34.5K.
  • Eli Lilly made up 0.54% of Darden Wealth Group's portfolio in Q1 2026, its #40 holding.
  • Darden Wealth Group first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • Darden Wealth Group's Eli Lilly position peaked at $1.34M in Q3 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Darden Wealth Group's 13F filing for Q1 2026, filed 8 May 2026.